[Addiction : what's new in 2024].
Yasser Khazaal, Maèva Flayelle, Joël Billieux, Louise Penzenstadler, Tiphaine Robet, Radu Iuga, Ansgar Rougemont-Bücking, Isabelle Gothuey, André Kuntz, Rafik Bouzegaou, Ghazaleh Soleimani, Hamed Ekhtiari, Germano Vera Cruz, Daniele Zullino
Revue medicale suisse January 29, 2025 DOI: 10.53738/revmed.2025.21.903.183 (opens in new tab) via PubMed
Summary
AI-generated from the abstractAddiction medicine faces new challenges from shifts in the drug market and the increasing digitalization of environments. The field is advancing through robust research in psychedelic-assisted psychotherapy, as well as the rapid growth of non-invasive brain stimulation techniques and artificial intelligence-driven research, which may transform clinical practice.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Key finding | Argues that addiction medicine is confronting challenges from modern changes and is advancing through psychedelic-assisted psychotherapy, non-invasive brain stimulation, and AI-driven research. |
Abstract
Addiction medicine is confronting challenges brought about by changes in our modern world, including shifts in the drug market and the increasing digitalization of our environments. This article highlights some of these challenges and explores potential strategies to address them. The field is also advancing through robust research momentum in psychedelic-assisted psychotherapy. Additionally, the rapid growth of non-invasive brain stimulation techniques and artificial intelligence-driven research demonstrates the integration of cutting-edge technologies into addiction medicine, with the potential to transform clinical practice in the years ahead.